Resmed Inc RMD:NYSE
RT Quote | Last NYSE Arca, VOL From CTA | USD
After Hours: Last | 5:45 PM EDT189.00
+2.54 (+1.36%)
+2.54 (+1.36%)Volume
114,932
Close
186.46+3.64 (+1.99%)
+3.64 (+1.99%)Volume
1,567,692
52 week range
180.27 - 293.81
- Open185.00
- Day High190.80
- Day Low184.07
- Prev Close182.82
- 52 Week High293.81
- 52 Week High Date08/22/25
- 52 Week Low180.27
- 52 Week Low Date06/02/26
Latest On Resmed Inc
Key Stats
- Market Cap27.047B
- Shares Out145.06M
- 10 Day Average Volume1.77M
- Dividend2.40
- Dividend Yield1.29%
- Beta0.78
KEY STATS
- Open185.00
- Day High190.80
- Day Low184.07
- Prev Close182.82
- 52 Week High293.81
- 52 Week High Date08/22/25
- 52 Week Low180.27
- 52 Week Low Date06/02/26
- Market Cap27.047B
- Shares Out145.06M
- 10 Day Average Volume1.77M
- Dividend2.40
- Dividend Yield1.29%
- Beta0.78
RATIOS/PROFITABILITY
- EPS (TTM)10.37
- P/E (TTM)17.98
- Fwd P/E (NTM)15.64
- EBITDA (TTM)2.152B
- ROE (TTM)25.25%
- Revenue (TTM)5.538B
- Gross Margin (TTM)61.56%
- Net Margin (TTM)27.44%
- Debt To Equity (MRQ)10.23%
EVENTS
- Earnings Date07/29/2026(est)
- Ex Div Date05/14/2026
- Div Amount0.60
- Split Date-
- Split Factor-
Content From Our Affiliates
Related Video
watch now
Profile
MOREResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment....
Michael Farrell
Chairman of the Board, Chief Executive Officer
Peter Farrell Ph.D.
Founder and Chairman Emeritus
Aaron Bloomer
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Michael Rider
Global General Counsel, Company Secretary
Address
9001 Spectrum Center Blvd
San Diego, CA
92123
United States